Seagen Inc (NASDAQ:SGEN) shares are trading higher Monday after Pfizer Inc (NYSE:PFE) announced plans to acquire the global biotech company. What Happened: Seagen and Pfizer entered into a definitive ...

Just days ago, biotech company Seagen (SGEN) jumped after reports emerged that Merck (MRK) was interested in buying the company. Now, the company gained another 3.5% in pre-market trading on Friday ...

Seagen expects the new, 270,000-square-foot biologics facility in Everett, Washington will eventually employ up to 200 staffers. (Business Wire) With a potential market expansion on the horizon, ...

Seagen staffers recently found themselves in a similar bind when Pfizer in March confirmed plans to cancel the buildout of a 270,000-square-foot Seagen facility in Everett, Washington. (Annalee ...

Pfizer's (NYSE:PFE) acquisition of Seagen (NASDAQ:SGEN), announced in March, is expected to complement the pharma giant's current portfolio of oncology therapies. Seagen focuses on antibody-drug ...

When it comes to churning out medicines that fight cancer, Seagen (NASDAQ: SGEN) is a heavyweight. The biotech's global footprint is expanding thanks to regulatory approvals in Europe, and its sales ...

Shakespeare’s paean to love, contained in his Sonnet 116, could just as well describe the passion held by some of the largest pharmas for Seagen (SGEN), the antibody-drug conjugate (ADC) developer ...

Seagen (NASDAQ:SGEN) said in an SEC filing that it and Pfizer (NYSE:PFE) have received a second request from the Federal Trade Commission for more information regarding their planned merger. The ...

Seattle-area biotech experts are eying the past warily in the wake of this week’s news that Pfizer plans to acquire Bothell, Wash.-based Seagen for a whopping $43 billion. Most previous acquisitions ...

After a roller coaster of conjecture and stalled talks, cancer drugmaker Seagen has finally been snatched up. Pfizer agreed to buy the firm, formerly known as Seattle Genetics, for $43 billion on ...